BronxCare’s Medical Oncology and Hematology team offer an unparalleled expertise in all facets of cancer care and blood disorders. Its physicians are board-certified in internal medicine, medical oncology, and hematology. Services provided include treatment and management of bladder, breast, head & neck, kidney, lung, testicular, thyroid, melanoma, sarcoma, pancreatic, prostate, and salivary gland cancers, as well as leukemia and lymphoma, among other cancer-related areas.

Innovative diagnostic and therapeutic treatment options are available to oncology patients. These options are based on the unique cancer “fingerprint” of each patient. As a result, the medical oncology team tailors an individualized treatment plan to manage malignancies with treatment options including chemotherapy and immunotherapy. Next generation sequencing is also performed in some cases to offer patients a precision oncology approach.

The Medical Oncology and Hematology team is a vital component of BronxCare Mount Sinai Comprehensive Cancer Care.

In the Oncology area, Dr. Thanh-Ha Luong, Dr. Valentina Moirangthem, Dr. Philip Rubin, and Dr. Anas El Mogharbel are supporting the efforts of BronxCare’s Outpatient Cancer facility, under the direction of Dr. Kevin R. Jain, Section Chief, Medical Oncology/Hematology.

BronxCare’s state-of-the-art oncology pharmacy provides patients with comprehensive and well-balanced services in solid and hematologic malignancies at the inpatient and outpatient levels. The pharmacy team, comprised of board-certified clinical pharmacists and highly trained chemotherapy compounding pharmacists, strives to provide full medical support to patients undergoing treatment by providing pharmacy services in a caring environment. Pharmacists maintain close communication with hematology/oncology physicians, in addition to nursing and registration staff, to enable completeness in patient care.

The pharmacy team is highly trained, with an expertise in medication management services across the care continuum for common chemotherapy complications: pain management, nausea/vomiting, diarrhea, anemia, depression, and fatigue, among other side effects. In addition, in-house compounding services are performed following USP 797 and 800 standards to ensure the safety of staff and patients during the receipt, preparation, administration, and monitoring of anti-cancer agents.